Keloids respond poorly to treatment. The gold standard for treatment is intra-lesional steroids. Topical tacrolimus has shown some effect in some recent studies. If an adequate response can be demonstrated, it could well replace the current gold-standard. Ideally tacrolimus should be compared to intra-lesional steroids. This protocol describes a placebo trial and is FREE to download.